Biomarkers in Hematology and Oncology

Biomarkers are the biological molecules found in blood, other body fluids, or tissues, which explains a symbol of a normal or anomalous progression, or of a condition or illness. These are used to see how well the body answers to a therapy for an illness or disorder. These are also termed as molecular marker and signature molecule.

A cancer biomarker is a gene or substance that reveal the presence of cancer in the body that are particularly associated with genetic mutations, which determine whether individuals are susceptible to particular type of cancer.

Biomarkers are used in three principal modes in medicine and cancer research:

1. To aid detect complaints in the identification of early phase Malignances

2. To predict how antagonistic an ailment is (Prognostic)

3. To envisage how sound a patient will retort to therapy

  • Genetic markers
  • Tumour markers
  • Cancer biomarkers
  • Diagnostic Biomarker
  • Biomarker Discovery

Related Conference of Biomarkers in Hematology and Oncology

October 17-18, 2019

2nd International conference on blood disorders 2019

Osaka, Japan
October 23-24, 2019

13th World Congress on Hematology and Oncology

| Tokyo, Japan

17th World Hematology & Blood Disorders Conference

November 25-26, 2019 Paris, France
March 16-17, 2020

18th World Hematology Congress

London, UK

Biomarkers in Hematology and Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in